Avalanche Biotechnologies CFO Linda Rubinstein's 2023 pay jumps 1,957% to $2.3M
Avalanche Biotechnologies reports 2023 executive compensation
By ExecPay News
Published: May 2, 2024
Avalanche Biotechnologies reported fiscal year 2023 executive compensation information on May 2, 2024.
In 2023, four executives at Avalanche Biotechnologies received on average a compensation package of $1.4M, a 8% increase compared to previous year.
Average pay of disclosed executives at Avalanche Biotechnologies
Linda Rubinstein, Chief Financial Officer, received $2.3M in total, which increased by 1,957% compared to 2022. 59% of Rubinstein's compensation, or $1.4M, was in option awards. Rubinstein also received $68K in non-equity incentive plan, $198K in salary, as well as $675K in other compensation.
For fiscal year 2023, the median employee pay was $229,443 at Avalanche Biotechnologies. Therefore, the ratio of Linda Rubinstein's pay to the median employee pay was 10 to one.
Laurent Fischer, Chief Executive Officer, received a compensation package of $1.5M, which decreased by 47% compared to previous year. 43% of the compensation package, or $672K, was in salary.
Kishor Peter Soparkar, Chief Operating Officer, earned $903K in 2023, a 33% decrease compared to previous year.
Setareh Seyedkazemi, Chief Development Officer, received $799K in 2023, which decreases by 47% compared to 2022.
Related executives
You may also like
Source: SEC filing on May 2, 2024.